NeurologyLive® Friday 5 — September 29, 2023

News
Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 29, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: IJMSC September/October 2023 Highlights

Review the latest peer-reviewed articles dedicated to the multidisciplinary management of multiple sclerosis published in the International Journal of MS Care.

IJMSC September/October 2023 Highlights

2: Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis

Jason Freeman, MD, MBA, and Brandon Brown, PharmD, discuss the poster “Five-Year Safety of Ofatumumab in People Living with Relapsing Multiple Sclerosis” presented at AAN 2023. Sponsored By Novartis.

Five-Year Safety of Ofatumumab in People Living With Relapsing Multiple Sclerosis

3: NeuroVoices: Craig Blackstone, MD, PhD, FANA, on Helping Path Research Careers for Young Medical Professionals

In this recent Q&A, the chief of the Movement Disorders Division at Mass General Hospital provided context on the goals behind the research careers reimagined course at the recently concluded ANA Annual Meeting.

NeuroVoices: Craig Blackstone, MD, PhD, FANA, on Helping Path Research Careers for Young Medical Professionals

4: Challenges With Access, Delivery of New ALS Therapeutics: Richard Bedlack, MD, PhD, MS

The director of the Duke ALS Clinic at Duke Health provided perspective on the issues with getting newly approved ALS therapies to patients who need them the most. [WATCH TIME: 4 minutes]

Challenges With Access, Delivery of New ALS Therapeutics: Richard Bedlack, MD, PhD, MS

5: The Complex Landscape of NMOSD and MOGAD-Associated Diseases: Erin Longbrake, MD, PhD

The associate professor of neurology at Yale School of Medicine discussed the differentiation of neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein -associated disease from multiple sclerosis at IFN 2023. [WATCH TIME: 5 minutes]

The Complex Landscape of NMOSD and MOGAD-Associated Diseases: Erin Longbrake, MD, PhD
Related Videos
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.